ISLAMABAD, MARCH 20 (ONLINE): Amycretin, a new weight loss drug developed by Novo Nordisk, has shown promising early results and is potentially more effective than the company’s established treatments, Ozempic and Wegovy. In a phase 1 trial, the drug was found to significantly reduce body […]